Phishing surge, LinkedIn tracking claims, spyware use, and rising stealers expose growing abuse of trusted systems.

The biggest story of the week is a new massive supply chain breach, which appears to be unrelated to the previous massive supply chain breaches, this time of the Axios HTTP project. Axios was ...

Developers using the axios package from npm may have downloaded a malicous version that drops a Remote Access Trojan ...

WASHINGTON, March 11 (Reuters) - U.S. President Donald Trump told Axios on Wednesday that there's "practically nothing left" to target in Iran and that the war there will end "soon." "Little this and ...

So, you’ve got to work with an API, and the documentation looks like a foreign language textbook written by a robot? Yeah, I’ve been there. It’s like trying to assemble flat-pack furniture with ...

Feb 22 (Reuters) - United States negotiators are ready to hold another round of talks with Iran on Friday in Geneva if they receive a detailed Iranian proposal for a nuclear deal in the next 48 hours, ...

Feb 14 (Reuters) - President Donald Trump and Israeli Prime Minister Benjamin Netanyahu agreed at a White House meeting on Wednesday that the U.S. would work to reduce Iran's oil exports to China, ...

Building your very first REST API might sound like a big task, but honestly, it’s more about getting started and learning as you go. Think of it like learning to cook; you start with simple recipes, ...

Axios changed a headline, which claimed crime dropped across major American cities despite efforts by President Donald Trump’s administration to combat it, following extensive public backlash. The ...

see more of our stories on Google. Add Axios on Google Mistral AI's Mensch in conversation with Axios' Ina Fried on the Axios House Stage. Photo: Dani Ammann Photography for Axios.

see more of our stories on Google. Add Axios on Google Harvey Schwartz, Laurent Mekies and Mike Allen converse on the Axios House stage. Photo: Dani Ammann Photography for Axios.

The Axios stent and delivery system [Image courtesy of Boston Scientific] The FDA has flagged a Boston Scientific (NYSE: BSX) + recall of its Axios stent and delivery system as potentially serious.